Study of APD421 as PONV Treatment (Prior Prophylaxis)
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
Double-blind, randomised, parallel-group, placebo-controlled, adaptive, seamless,
dose-selecting study to compare the efficacy of APD421 to placebo as treatment of established
PONV, in patients who have had prior PONV prophylaxis.